Summit Therapeutics Inc. (SMMT) NASDAQ
16.87
-1.27(-7.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
16.87
-1.27(-7.00%)
Currency In USD
| Market Cap | 13.08B |
| Enterprise Value | 12.93B |
| P/E Ratio | -12.43 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 31.6 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -12.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.14 |
| Return On Equity | -3.41 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -1.08B |
| Net Income | -1.08B |
| Diluted EPS | -1.44 |
| Total Cash | 454.05M |
| Total Cash/Share | 0.59 |
| Total Debt | 15.2M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 7.41 |
| Book Value Per Share | 0.53 |
| 52-Week Change | -26.94 |
| 52-Week High | 30.98 |
| 52-Week Low | 13.83 |
| Moving Average 50 Days | 18.75 |
| Moving Average 200 Days | 19.3 |
| Average Volume | 3.33M |
| Shares Outstanding | 775.37M |
| % Held by Institutions | 3.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |